Jci_page_head_homepage_01 Jci_page_head_homepage_02
Cecile M. Fremond, Vladimir Yeremeev, Delphine M. Nicolle, Muazzam Jacobs, Valerie F. Quesniaux, Bernhard Ryffel
Published in Volume 114, Issue 12
J Clin Invest. 2004; 114(12):1790–1799 doi:10.1172/JCI21027
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6

BCG vaccination confers an initial protection to MTB-challenged MyD88–/– mice. MyD88–/– mice and control mice were either immunized by s.c. injection of M. bovis BCG (105 CFU) or left naive and 5 weeks later challenged by MTB H37Rv aerogenic infection (200 CFU per mouse i.n.). The mice were monitored for body weight (A) or survival (B) or were sacrificed at 4 weeks after MTB challenge and analyzed for lung weight (C) and bacterial counts (D) as in Figure 2 (A: n = 7–8 mice per group from 1 representative experiment out of 2; B: n = 11–13 mice per group from 2 experiments; C and D: n = 4 per group from 1 representative experiment out of 3; *P – 0.05; **P – 0.01).